RIL
TERN

Rothschild Investment LLC’s Terns Pharmaceuticals TERN Stock Holding History

Rothschild Investment LLC’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-370
Closed -$19.5K – 3714
2026
Q1 		$19.5K Buy
370
+59
+19% +$2.42K ﹤0.01% 1423
2025
Q4 		$12.6K Buy
311
+31
+11% +$716 ﹤0.01% 1494
2025
Q3 		$2.1K Hold
280
– – ﹤0.01% 2204
2025
Q2 		$1.04K Buy
280
+245
+700% +$765 ﹤0.01% 2447
2025
Q1 		$97 Sell
35
-90
-72% -$368 ﹤0.01% 2975
2024
Q4 		$693 Buy
125
+15
+14% +$102 ﹤0.01% 2413
2024
Q3 		$917 Buy
110
+70
+175% +$576 ﹤0.01% 2230
2024
Q2 		$272 Buy
+40
New +$242 ﹤0.01% 2345

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rothschild Investment LLC's TERN Position: Q2 2026 in Review

Rothschild Investment LLC sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 370 shares — an estimated $19.5K sold.

Rothschild Investment LLC first reported a position in TERN in Q2 2024 and held it in 8 quarters. The position peaked at $19.5K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Rothschild Investment LLC reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 370 Terns Pharmaceuticals shares in Q2 2026, an estimated $19.5K.
  • Rothschild Investment LLC first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 8 quarters.
  • Rothschild Investment LLC's Terns Pharmaceuticals position peaked at $19.5K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.